Addition of the antipsychotic lumateperone (Caplyta) to an existing antidepressant improved symptoms of depression in a randomized, double-blind phase III trial. Among 484 patients with major ...

Company remains sharply focused on its ongoing global development program for crofelemer for rare IF diseases Near-term ...

The use of 42 mg lumateperone combined with antidepressant therapy was linked to significantly reduced severity of depression and anxiety, as well as greater response and remission rates, and was ...

In treatment of depression with adjunctive aripiprazole, early improvement (week 2) was a significant predictor of remission, and lack of improvement was associated with nonremission. Post hoc pooled ...

NEW YORK — Of the adjunctive treatments available for alopecia, the list of those supported by data is fairly short, but clinicians are inevitably asked about others, and it can be helpful to ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved once-daily guanfacine as adjunctive therapy for the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Adjunctive antidepressants led to no significant delay ...

Active ingredient: Rufinamide 200 mg, 400 mg; scored tabs. Indication: Adjunctive treatment of seizures in Lennox-Gastaut syndrome (LGS). Pharmacology: LGS is a seizure disorder characterized by ...

The U.S. CMS has crafted a payment policy that covers both adjunctive and non-adjunctive continuous glucose monitors (CGMs) in the final rule for durable medical equipment (DME). Medtronic plc, of ...